Savara (SVRA) Revenue (2013 - 2020)

Savara (SVRA) reported Revenue of $1000.0 for Q4 2020, down 99.61% quarter-over-quarter from $256000.0 in Q3 2020.

Savara (SVRA) Revenue (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of Revenue data on file, last reported at $1000.0 in Q4 2020.

Revenue for Q4 2020 came in at $1000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $1000.0 (changed N/A YoY), and the FY2020 annual result was $257000.0, changed N/A from the prior year.
Revenue declined to $1000.0 in Q4 2020 per SVRA's latest filing, from $256000.0 in the prior quarter.
Over five years, Revenue peaked at $400000.0 in Q4 2016 and troughed at -$94000.0 in Q2 2017.
A 3-year average of $117000.0 and a median of $69500.0 in 2016 frame the typical range for Revenue.
On a YoY basis, Revenue climbed as much as 640.74% in 2016 and fell as far as 640.74% in 2016.
A 3-year view of Revenue shows it stood at $400000.0 in 2016, then slumped by 123.5% to -$94000.0 in 2017, then jumped by 101.06% to $1000.0 in 2020.
Business Quant data shows SVRA's Revenue at $1000.0 in Q4 2020, $256000.0 in Q3 2020, and -$94000.0 in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	5.21 Mn
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	306.30 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	2.99 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Savara	1.39 Bn	1.39 Bn	-	-

Download Data